Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
3.
HIV Med ; 20(1): 33-37, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30318718

RESUMEN

OBJECTIVES: HIV elite controllers (ECs) are a unique subgroup of HIV-positive patients who are long-term virologically suppressed in the absence of antiretroviral treatment (ART). The prevalence of this subgroup is estimated to be < 1%. Various cohorts of ECs have been described in developed countries, most of which have been demographically heterogeneous. The aim of this study was to identify ECs in two large African cohorts and to estimate their prevalence in a relatively genetically homogenous population. METHODS: We screened two cohorts of HIV-positive Ethiopian patients. The first cohort resided in Mekelle, Ethiopia. The second was comprised of HIV-positive Ethiopian immigrants in Israel. In the Mekelle cohort, ART-naïve subjects with stable CD4 counts were prospectively screened using two measurements of viral load 6 months apart. Subjects were defined as ECs when both measurements were undetectable. In the Israeli cohort, subjects with consistently undetectable viral loads (mean of 17 viral load measurements/patient) and stable CD4 count > 500 cells/µL were defined as ECs. RESULTS: In the Mekelle cohort, 16 of 9515 patients (0.16%) fitted the definition of EC, whereas seven of 1160 (0.6%) in the Israeli cohort were identified as ECs (P = 0.011). CONCLUSIONS: This is the first large-scale screening for HIV-positive ECs to be performed in entirely African cohorts. The overall prevalence of ECs is within the range of that previously described in developing countries. The significant difference in prevalence between the two cohorts of similar genetic background is probably a consequence of selection bias but warrants further investigation into possible environmental factors which may underlie the EC state.


Asunto(s)
Infecciones por VIH/epidemiología , Infecciones por VIH/inmunología , VIH-1/fisiología , Adulto , Recuento de Linfocito CD4 , Estudios de Cohortes , Emigrantes e Inmigrantes/estadística & datos numéricos , Etiopía/epidemiología , Femenino , Infecciones por VIH/virología , Humanos , Israel/epidemiología , Israel/etnología , Masculino , Tamizaje Masivo , Prevalencia , Carga Viral , Adulto Joven
5.
Clin Microbiol Infect ; 21(5): 459-63, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25770747

RESUMEN

Q fever, caused by Coxiella burnetii, can present as an outbreak of acute disease ranging from asymptomatic disease, pneumonia, hepatitis or fever of unknown origin, which can progress to a chronic disease, most frequently endocarditis. The occurrence of Q fever within families is rarely described, and in most cases presents with uniform acute disease manifestations. Here we present a familial cluster of Q fever presenting as highly variable synchronous manifestations in four of five family members, including prolonged fever of unknown origin, asymptomatic carrier state, hepatitis, and chronic endocarditis developing in the absence of previous symptoms. This case series highlights the possibility of Q fever developing in cohabitated individuals with highly variable symptoms masking the common disease etiology. Screening of all exposed individuals, even those not clinically suspected to be infected, may enable to better identify, treat and prevent progression to chronic disease.


Asunto(s)
Coxiella burnetii/aislamiento & purificación , Salud de la Familia , Fiebre Q/epidemiología , Fiebre Q/patología , Adolescente , Adulto , Análisis por Conglomerados , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven
6.
Clin Microbiol Infect ; 19(8): 752-6, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23005038

RESUMEN

The emergence of fluconazole-resistant Candida (FRC) is worrisome, but little is known about susceptibility patterns in different nosocomial settings. We prospectively analysed Candida bloodstream isolates in 18 medical centres in Israel (six tertiary-care and 12 community hospitals). The study included 444 episodes of candidaemia (450 patient-specific isolates, 8.5% fluconazole-resistant). Institutional FRC bloodstream infection rates correlated with annual inpatient days, and were strongly associated with the presence and activity of haematology/oncology services. Infection with Candida krusei and fluconazole-resistant Candida glabrata occurred exclusively in hospitals with >600 beds. These findings suggest that empirical antifungal strategies should be tailored to the nosocomial setting.


Asunto(s)
Antifúngicos/farmacología , Candida/efectos de los fármacos , Candidemia/epidemiología , Infección Hospitalaria/epidemiología , Farmacorresistencia Fúngica , Fluconazol/farmacología , Adulto , Anciano , Candida/aislamiento & purificación , Candida glabrata , Femenino , Hospitales , Humanos , Israel/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Prospectivos
7.
Clin Microbiol Infect ; 15(7): 693-7, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19624514

RESUMEN

Rhinocerebral mucormycosis is a rare disease, affecting almost exclusively patients with known predisposing conditions such as diabetes mellitus, immunocompromised status, haemochromatosis or major trauma. Subsequent to a case of rhinocerebral mucormycosis in a 78-year-old woman without any known risk factor, we reviewed the published English-language literature and found an additional 72 cases. Reviewing all the published case series of mucormycosis involving any site, the proportion of apparently normal hosts among cases of rhinocerebral mucormycosis was found to be 9.06% (95% confidence interval 6.7-11.8). These findings suggest that rhinocerebral mucormycosis in patients without known predisposing factors is more prevalent than was previously believed.


Asunto(s)
Encefalopatías/diagnóstico , Mucormicosis/diagnóstico , Enfermedades Nasales/diagnóstico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Encefalopatías/microbiología , Niño , Preescolar , Resultado Fatal , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Mucormicosis/microbiología , Enfermedades Nasales/microbiología , Adulto Joven
8.
Harefuah ; 142(6): 421-5, 486, 2003 Jun.
Artículo en Hebreo | MEDLINE | ID: mdl-12858825

RESUMEN

Primary sclerosing cholangitis (PSC), a condition usually associated with inflammatory bowel disease, is a chronic inflammatory state of the biliary tract characterized by fibrotic strictures of intrahepatic and extrahepatic bile ducts. Between 5-15% of patients with PSC will develop cholangiocarcinoma. The diagnosis of cholangiocarcinoma in patients with PSC is difficult, as it is often impossible to distinguish benign PSC-related strictures from lesions associated with cholangiocarcinoma. Consequently, most patients are diagnosed with advanced disease and have a dismal prognosis at the time of diagnosis. The importance of characterizing patients with PSC who have an increased risk of developing cholangiocarcinoma and of developing means for early detection of this disease cannot be over-emphasized. Detection of cholangiocarcinoma in asymptomatic patients is additionally important, as this condition is considered a contraindication for liver transplantation. We describe a patient with longstanding Crohn's disease and PSC who developed cholangiocarcinoma, and review the literature regarding risk factors for cholangiocarcinoma, early detection of cholangiocarcinoma and the significance of existing cholangiocarcinoma in the context of liver transplantation.


Asunto(s)
Neoplasias de los Conductos Biliares/etiología , Conductos Biliares Intrahepáticos , Colangiocarcinoma/etiología , Colangitis Esclerosante/complicaciones , Adulto , Neoplasias de los Conductos Biliares/cirugía , Colangiocarcinoma/cirugía , Enfermedad de Crohn/complicaciones , Humanos , Trasplante de Hígado , Masculino , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA